|
000
| 01157nam##2200241za#4500 |
|---|
| 001 | 9.692993 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624233449 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2010||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-14645-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-118/2010E-PDF |
|---|
| 110 | 1 |aCanada. |bHealth Canada. |
|---|
| 245 | 10|aGuidance document for source establishments - reporting adverse reactions to human cells, tissues and organs / |h[electronic resource]|c[issued by] Canada Vigilance Adverse Reaction Monitoring Program and Database, a program of MedEffect Canada. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada |cc2010. |
|---|
| 300 | |a27p.|bglossary, references, table |
|---|
| 500 | |a"Effective date: 2010-05-25" |
|---|
| 590 | |a10-36|b2010-09-10 |
|---|
| 690 | 07|aAdverse effects|2gcpds |
|---|
| 775 | 08|tDocumentation d'orientation à l'intention des établissements centraux - déclaration des effets indésirables de cellules, tissus et organes humains / |w(CaOODSP)9.637201 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s183 KB|uhttps://publications.gc.ca/collections/collection_2010/sc-hc/H164-118-2010-eng.pdf |
|---|